Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 29 (9) , 2677-2690
Abstract
No abstract availableKeywords
Funding Information
- Fujifilm Corporation
- Pfizer Japan
- Daiichi-Sankyo
- Bristol-Myers Squibb
- Otsuka Pharmaceutical
- Nagoya University
- Amgen K.K
- Astellas Pharma
- Chugai Pharmaceutical
- Kyowa Kirin
- Eisai
- Japan Society for the Promotion of Science (18k08351)
- Japan Society for the Promotion of Science (15k09497)
- Japan Society for the Promotion of Science (15ck0106067h0002)
- Japan Society for the Promotion of Science (17ck0106291h0001)
- Japan Society for the Promotion of Science (19ek0510022h0003)
- Japan Agency for Medical Research and Development
- Takeda Pharmaceutical Company
- Sanofi K.K.
- Prince of Songkla University
- Celgene
This publication has 47 references indexed in Scilit:
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T CellsClinical Cancer Research, 2013
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic LeukemiaScience Translational Medicine, 2013
- The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood CancerClinical Cancer Research, 2012
- Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cellsBlood, 2012
- Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor EradicationMolecular Therapy, 2010
- Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral InfectionImmunity, 2007
- CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor EnhancesIn vivoPersistence and Antitumor Efficacy of Adoptively Transferred T CellsCancer Research, 2006
- NFAT proteins: key regulators of T-cell development and functionNature Reviews Immunology, 2005
- Synergistic B Cell Activation by CD40 and the B Cell Antigen ReceptorJournal of Biological Chemistry, 2004